ifosfamide has been researched along with Movement Disorders in 2 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide is a widely used chemotherapeutic agent for the treatment of a broad spectrum of solid tumors." | 1.36 | Ifosfamide-induced encephalopathy and movement disorder. ( Ames, B; Chaffee, S; Kim, J; Lewis, LD; Morse, R, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, CL | 1 |
| Zhou, H | 1 |
| Chai, AP | 1 |
| Yang, YX | 1 |
| Mao, RR | 1 |
| Xu, L | 1 |
| Ames, B | 1 |
| Lewis, LD | 1 |
| Chaffee, S | 1 |
| Kim, J | 1 |
| Morse, R | 1 |
2 other studies available for ifosfamide and Movement Disorders
| Article | Year |
|---|---|
Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice.
Topics: Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Infarction; Bra | 2015 |
Ifosfamide-induced encephalopathy and movement disorder.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Child; Female; Humans | 2010 |